Bone Marrow TransplantationBlood Transfusion, AutologousBone MarrowTransplantation, HomologousTransplantation, AutologousBone Marrow CellsGraft vs Host DiseaseHematopoietic Stem Cell TransplantationWhole-Body IrradiationLiver TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaTransplantation ChimeraGraft SurvivalTissue DonorsKidney TransplantationBusulfanBone Marrow PurgingBone and BonesHistocompatibility TestingCyclophosphamideHematopoietic Stem CellsHistocompatibilityTransplantation, IsogeneicCombined Modality TherapyTreatment OutcomeRecurrenceBone Marrow DiseasesRemission InductionStem Cell TransplantationHematopoiesisGraft RejectionHeart TransplantationImmunosuppressive AgentsTime FactorsLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraTransplantation ImmunologyHematologic NeoplasmsMice, Inbred C57BLLung TransplantationRetrospective StudiesOperative Blood SalvagePrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone Marrow ExaminationImmunosuppressionAcute DiseaseGraft vs Host ReactionLymphoma, Non-HodgkinLeukemia, MyeloidSurvival AnalysisBlood TransfusionLymphocyte DepletionLeukocyte TransfusionBone Marrow NeoplasmsT-LymphocytesOrgan TransplantationMelphalanHLA AntigensAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssaySevere Combined ImmunodeficiencyMyelodysplastic SyndromesFollow-Up StudiesCyclosporineChimeraSurvival RateActuarial AnalysisMultiple MyelomaBlood Loss, SurgicalHematologic DiseasesLymphocyte TransfusionCarmustineGranulocyte Colony-Stimulating FactorCell TransplantationHodgkin DiseaseCytarabineGraft vs Tumor EffectNuclear FamilyAntigens, CD34Disease-Free SurvivalCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectPancreas TransplantationCell DifferentiationIslets of Langerhans TransplantationBone RemodelingPancytopeniaEtoposidePeripheral Blood Stem Cell TransplantationCord Blood Stem Cell TransplantationPostoperative ComplicationsTransplantationBlood Cell CountLymphomaSpleen